Germany
CereGate GmbH, established in 2019 and headquartered in Germany, is a leading innovator in the Computer-Brain Interface (CBI) sector. With its compelling slogan, "A sense of wonder," the company is at the forefront of neurotechnology, aiming to enhance human senses through minimally invasive solutions that bridge computers and the nervous system.
CereGate's platform uniquely leverages existing neuromodulation implants, fostering seamless human-computer interaction. The company has demonstrated proven success through human trials and maintains strong industry partnerships, positioning itself as a crucial player in advancing neurotherapy and sensory restoration.
Recently, CereGate secured an Early VC investment on 01 August 2024, backed by notable investors like Heal Capital, TruVenturo, Apeiron Investment Group, HTGF, 468 Capital, and CARMA FUND Management GmbH. This investment highlights the significant confidence in CereGate's promising growth trajectory and innovative potential.
